BCRX Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

$12.60  +0.24 (1.90%)
As of 09/30/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/07/2001
Outstanding shares:  185,945,016
Average volume:  2,435,492
Market cap:   $2,298,280,398
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2100362
Valuation   (See tab for details)
PE ratio:   -12.08
PB ratio:   65.97
PS ratio:   12.22
Return on equity:   118.12%
Net income %:   -103.16%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy